2026 年至 2032 年神经復健设备市场（按产品、应用、最终用户和地区）

神经復健设备市场评估 - 2026-2032

中风、帕金森氏症和脊髓损伤等神经系统疾病的发生率不断上升，是神经復健设备市场的主要驱动因素。随着全球人口老化，这些疾病的发生率也不断上升，导致对有效復健方案的需求庞大。科技的进步正在推动新型神经復健设备的开发，这些设备可以改善患者的康復效果并提高患者的独立性。所有这些因素都推动了对神经復健设备的需求不断增长。预计到2024年，市场规模将达到24.6643亿美元，到2032年将达到约63.7374亿美元。

对早期疗育和以患者为中心的治疗的日益重视正在推动市场扩张。神经復健设备在改善神经病变患者的生活品质方面发挥关键作用，因为它能够加快復健速度并增强功能。政府的支持措施和不断增长的医疗支出为市场成长创造了有利的环境。这些因素共同推动了神经復健设备市场的显着成长。对经济高效的神经復健设备的需求不断增长，使得该市场在2026-2032年期间的复合年增长率达到13.90%。

神经復健设备市场定义/概述

神经復健设备是帮助神经系统疾病患者恢復或改善其运动、感觉和认知能力的专用设备。这些设备使用机器人、虚拟实境和脑机介面等不同技术来辅助復健过程。中风、创伤性脑损伤和神经退化性疾病等疾病可透过结构化和客製化的疗法进行治疗，旨在改善神经元的可塑性和功能恢復。

神经復健设备正在临床环境中使用，并提供个人化的復健方案以改善患者的治疗效果：例如，机器人外骨骼透过引导肢体运动帮助中风患者恢復运动功能，虚拟实境系统为认知和运动练习提供有趣的环境。

随着人工智慧和机器学习的不断进步，这些设备能够更好地适应患者的独特需求，前景看好。即时神经回馈和更先进的脑机介面预计将透过客製化和改进治疗方案，提高神经病变患者的復健率和生活品质。

哪些因素推动了神经復健设备市场需求的激增？

预计神经復健设备市场将在预测期内推动技术进步。机器人技术、虚拟实境和脑机介面技术的进步正在增强这些设备的功能，使其在神经復健中发挥更大的作用。美国国家神经疾病与中风研究所 (NINDS) 在神经科学研究方面投入巨资，在 2020 财年拨款约 22.7 亿美元，彰显了其致力于开发新型神经復健技术的决心。预计这项投资将加速改进型復健技术的开发和应用，从而推动市场成长。

医疗保健支出的增加可能会推动神经復健设备市场的成长。医疗保健支出的大幅增长，例如美国全国医疗保健支出在2020年增长9.7%，达到4.1兆美元，显示人们越来越致力于投资最新的医疗技术。全球医疗保健支出的这种趋势透过增加这些技术的可及性并促进市场扩张，支持尖端神经復健设备的广泛应用。

患者的依从性将如何阻碍神经復健设备市场的成长？

患者的依从性对神经復健设备市场的成长至关重要，因为它会影响这些技术的有效性和普及程度。患者对既定復健方案的依从性高，可带来更好的治疗效果，进而增加对神经復健设备的需求。如果患者积极参与治疗并遵循治疗计划，康復计画的成功率将会提高，这不仅能证明这些设备的效用，还能鼓励进一步的投资和发展。另一方面，依从性低可能会降低设备的有效性，从而减缓市场成长。因此，提高患者的参与度和依从性对于维持和发展神经復健设备市场至关重要。

神经康復器材价格高昂，限制了其可近性和可负担性，影响了市场成长。昂贵的技术可能会限制其在资金充足的医疗机构和富裕患者的使用，从而限制其广泛普及并减缓市场成长。虽然技术发展可能会刺激创新并改善疗效，但经济障碍仍然是一个主要问题。透过製造突破、增强竞争和提供经济高效的解决方案来应对成本挑战，对于提高这些器械的可及性并推动市场成长至关重要。

目录

第一章 引言

• 市场定义
• 市场区隔
• 调查方法

第二章执行摘要

• 主要发现
• 市场概览
• 市集亮点

第三章市场概述

• 市场规模和成长潜力
• 市场趋势
• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析

第四章神经復健设备市场（按产品）

• 神经机器人系统
• 脑机介面
• 穿戴式装置
• 脑部刺激器

第五章神经復健设备市场（按应用）

• 中风
• 帕金森氏症
• 脑和脊髓损伤
• 脑性麻痹
• 多发性硬化症
• 其他的

第六章神经復健设备市场（依最终用户）

• 復健中心
• 医院和诊所
• 居家照护

第七章区域分析

• 北美洲
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 英国
• 德国
• 法国
• 义大利
• 亚太地区
• 中国
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中东和非洲
• 南非
• 沙乌地阿拉伯
• 阿拉伯聯合大公国

第八章市场动态

• 市场驱动因素
• 市场限制
• 市场机会
• COVID-19 市场影响

第九章 竞争态势

• 主要企业
• 市场占有率分析

第十章 公司简介

• Bionik Labs
• Ectron Ltd.
• REHABTRONICS INC.
• DIH International Limited（Hocoma AG）
• Abbott Laboratories（St. Jude Medical Inc.）
• MagVenture A/S
• Helius Medical Technologies
• Ekso Bionics
• Rehab-Robotics Company Limited
• Neurodan
• Rex Bionics
• Ottobock SE & Co. KGaA
• NeuroMetrix, Inc.

第十一章 市场展望与机会

• 新兴技术
• 未来市场趋势
• 投资机会

第十二章 附录

• 简称列表
• 来源和参考文献

Neurorehabilitation Devices Market Valuation - 2026-2032

In the neurorehabilitation devices market, the increased prevalence of neurological illnesses, such as stroke, Parkinson's disease, and spinal cord injuries, is a major driver. As the world population ages, the prevalence of these illnesses rises, resulting in a significant demand for effective rehabilitation options. Technological improvements have resulted in the development of novel neurorehabilitation devices that improve patient outcomes and increase independence. These factors all contribute to the growing need for neurorehabilitation devices. The market size surpass USD 2466.43 Million valued in 2024 to reach a valuation of around USD 6373.74 Million by 2032.

The growing emphasis on early intervention and patient-centered care is driving market expansion. Neurorehabilitation devices serve an important role in improving the quality of life for people with neurological impairments by allowing for speedier recovery and increased functional capacities. Supportive government measures and rising healthcare expenditures are creating a favorable environment for the market's growth. These combined factors are generating significant growth in the neurorehabilitation device market. The rising demand for cost-effective and efficient neurorehabilitation devices is enabling the market grow at a CAGR of 13.90% from 2026 to 2032.

Neurorehabilitation Devices Market: Definition/ Overview

Neurorehabilitation devices are specialized instruments that help people with neurological abnormalities regain or improve their motor, sensory, and cognitive abilities. These devices use a variety of technologies to aid in the rehabilitation process, including robotics, virtual reality, and brain-computer interfaces. They treat disorders such as stroke, traumatic brain injury, and neurodegenerative diseases using structured and customized therapy that aims to improve neuronal plasticity and functional recovery.

Neurorehabilitation devices are utilized in clinical settings to provide individualized rehabilitation regimens that improve patient results. For instance, robotic exoskeletons aid stroke sufferers in regaining motor function by guiding limb movements, whilst virtual reality systems provide interesting environments for cognitive and motor practice.

These devices show promise, with continual advances in artificial intelligence and machine learning improving their ability to adapt to unique patient demands. Real-time neurofeedback and more advanced brain-computer interfaces are projected to customize and improve therapy, thereby increasing recovery rates and quality of life for those with neurological disabilities.

What are the Factors that Surge the Demand for the Neurorehabilitation Devices Market?

The neurorehabilitation devices market are expected to propel the technological developments over the forecast period. Robotics, virtual reality, and brain-computer interface advances are boosting these devices' capabilities, making them more useful in neurological recovery. The National Institute of Neurological Disorders and Stroke (NINDS) has made a significant investment in neuroscience research, allocating nearly USD 2.27 Billion for fiscal year 2020, demonstrating its commitment to creating novel neurorehabilitation technology. This investment is likely to speed the development and implementation of improved rehabilitation techniques, hence boosting market growth.

The increase in healthcare expenditure is likely to boost the growth of the neurorehabilitation devices market. The significant increase in healthcare spending, as seen by a 9.7% increase to USD 4.1 Trillion in US national health spending in 2020, demonstrates an increasing commitment to investing in modern medical technology. This global growing trend in healthcare expenditure supports the broader adoption of cutting-edge neurorehabilitation devices by increasing access to these technologies and promoting market expansion.

How Does the Patient Compliance Hinder the Growth of the Neurorehabilitation Devices Market?

Patient compliance has a substantial impact on the growth of the neurorehabilitation device market because it influences the effectiveness and adoption of these technologies. High levels of patient compliance with prescribed rehabilitation regimens result in better outcomes, driving demand for neurorehabilitation devices. When patients are engaged and follow their therapy plans, rehabilitation program success rates improve, indicating the utility of these devices and driving further investment and development. Low compliance, on the other hand, can reduce a device's perceived effectiveness, thus slowing market growth. As a result, improving patient involvement and compliance is critical for maintaining and developing the neurorehabilitation devices market.

The high cost of neurorehabilitation devices has an impact on market growth by limiting access and affordability. Expensive technologies may limit their use to well-funded healthcare facilities or rich patients, restricting widespread adoption and slowing market growth. Although technological developments may promote innovation and enhance outcomes, the financial barrier continues to be a significant problem. Addressing cost challenges through manufacturing breakthroughs, increased competition, and cost-effective solutions is essential to making these devices more accessible and driving market growth.

Category-Wise Acumens

Will the Demand for Robotic Arms Propel the Neurorobotic Systems Segment?

Neurorobotic systems are now dominating the neurorehabilitation device market. Robotic arms are expected to create substantial expansion in the neurorobotic systems section of the neurorehabilitation device market. These modern robotic technologies improve the precision and effectiveness of rehabilitation by offering consistent and controlled support during therapy. Robotic arms improve patient outcomes by allowing for repetitive, task-specific exercises that promote neuronal plasticity, driving demand for neurorobotic systems. Their increasing integration into rehabilitation programs highlights their potential to transform neurorehabilitation, hence driving market growth in this category.

Exoskeletons are expected to fuel expansion in the neurorobotic systems section of the neurorehabilitation devices market. These exoskeletons provide total support and assistive mobility, improving the rehabilitation process by allowing patients with severe motor impairments to participate in meaningful physical activities. Their capacity to aid functional recovery through repetitive, regulated movements while also providing support during therapy makes them extremely effective in neurorehabilitation. The use of encompassing exoskeletons is expected to greatly boost the neurorobotic systems market, highlighting their expanding importance in advanced rehabilitation procedures.

The capacity to assess and quantify patient performance using these technologies has resulted in better treatment outcomes, making them the favored option for many rehabilitation centers.

Will the Trained Professionals Fuel the Hospitals & Clinics Segment for the Neurorehabilitation Devices Market?

The hospitals & clinics segment currently dominates the neurorehabilitation devices market. The presence of trained professionals will fuel expansion in the neurorehabilitation devices market's hospital and clinic segments. Skilled healthcare personnel are required to successfully adopt and optimize the use of modern neurorehabilitation technologies. Their knowledge ensures that patients receive proper, individualized therapy, allowing these devices to provide the most benefit possible. As hospitals and clinics continue to spend on training and hiring experienced personnel, they improve the quality and effectiveness of neurorehabilitation services, attracting more patients and increasing demand for these devices in the healthcare sector.

The neurorehabilitation devices market will propel the hospital and clinic segment combination of advanced facilities and trained experts. Advanced facilities equipped with cutting-edge neurorehabilitation devices, as well as qualified experts capable of utilizing this technology, ensure high-quality, tailored patient treatment. This collaboration improves the effectiveness of rehabilitation programs, bringing more patients to hospitals and clinics for treatment. As a result, demand for neurorehabilitation devices rises in these settings, driving market expansion in this sector.

Country/Region-wise Acumens

Will the Advanced Research and Development Boost the North American Region for the Neurorehabilitation Devices Market?

North America, holds a dominant position in the neurorehabilitation devices market. Advanced research and development are propelling the neurorehabilitation devices market in North America. The United States, in particular, is driving this effort with significant investments in neurological research and rehabilitation technologies. The National Institutes of Health (NIH) will spend around USD 9.7 Billion on brain research in fiscal year 2023, with a large chunk of that going toward neurorehabilitation. The National Institute of Neurological Disorders and Stroke (NINDS), got USD 2.8 Billion, up 3.5% from the previous year. The high frequency of neurological illnesses, such as 17% of children diagnosed with developmental impairments and 6.7 million Americans aged 65 and older living with Alzheimer's dementia, adds to this demand.

The well-established healthcare infrastructure will propel the neurorehabilitation devices market in North America. The United States and Canada, with their modern medical facilities and high adoption rates of cutting-edge technology, provide an ideal setting for market expansion. According to the American Hospital Association (AHA), there will be 6,093 hospitals in the United States in 2023, many of which will have cutting-edge rehabilitation departments.

The Centers for Medicare & Medicaid Services (CMS) estimated 1,166 inpatient rehabilitation centers in 2021, with specialized intensive care. The high prevalence of neurological illnesses, with the CDC estimating 795,000 strokes each year in the United States and the National Spinal Cord Injury Statistical Center reporting 17,900 new spinal cord injury cases each year, emphasizes the need for sophisticated neurorehabilitation technologies.

These factors emphasize a sizable patient population that could benefit from such devices, which is boosting demand for effective and novel neurorehabilitation solutions in North America.

Will the Urbanization and Increasing Disposable Incomes Expand the Asian Pacific Region for the Neurorehabilitation Devices Market?

The Asia-Pacific region is experiencing the most rapid growth in the neurorehabilitation devices market. Urbanization and increasing disposable incomes will fuel Asia Pacific's neurorehabilitation device market. Countries such as China, India, and Japan are undergoing fast urbanization and economic development, resulting in increased access to healthcare services and innovative medical technologies. According to UNESCAP, the region's urban population is expected to increase from 2.3 billion in 2019 to 3.5 billion by 2050, while the World Bank reports that GDP per capita in East Asia and the Pacific increased from $10,291 in 2010 to $14,480 in 2021, indicating a significant increase in purchasing power.

The prevalence of neurological disorders underscores this requirement, with the World Health Organization estimating that neurological disorders account for 6.8% of the overall disease burden in the Western Pacific and 8.7% in Southeast Asia. Furthermore, a 2023 study in The Lancet Neurology predicts that the number of persons with dementia in Asia Pacific will rise from 20.1 million in 2020 to 61.4 million by 2050. These considerations highlight the growing patient population in the Asia Pacific who could benefit from neurorehabilitation equipment, which is being driven by urbanization, increased incomes, and an increase in the prevalence of neurological illnesses.

Expanding healthcare awareness will drive the Asia Pacific neurorehabilitation devices market. In North America, rising public health education and patient empowerment in nations such as China, India, and Japan are leading to a greater understanding of neurological diseases and the benefits of rehabilitation therapies. As awareness rises, the region's large population of people suffering from neurological illnesses learns more about the importance of neurorehabilitation. This increased awareness, combined with a focus on improving long-term care and quality of life, is generating strong demand for neurorehabilitation equipment in the Asia Pacific region.

Competitive Landscape

The neurorehabilitation devices market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the neurorehabilitation devices market include:

• Bionik Labs
• Ectron Ltd.
• REHABTRONICS INC.
• DIH International Limited (Hocoma AG)
• Abbott Laboratories (St. Jude Medical Inc.)
• MagVenture A/S
• Helius Medical Technologies
• Ekso Bionics
• Rehab-Robotics Company Limited
• Neurodan
• Rex Bionics
• Ottobock SE & Co. KGaA
• NeuroMetrix, Inc.

Latest Developments

• In February 2023, MindMaze debuted Iza, a US Food and Drug Administration (FDA)-listed and CE-marked smart peripheral device for patients with weak hand motor abilities. Izar is intended to address a major vacuum in neurological care by providing the most effective treatment for manual dexterity and strength in a variety of neurological diseases.
• In September 2022, Sumitomo Pharma Co. Ltd. and MELTIN MMI agreed to launch and commercialize the MELTz(R) Hand Rehabilitation System. The product was co-developed by the aforementioned companies, but MELTIN acquired device certification as a distributor and manufacturer.
• In April 2022, Blackrock Neurotech purchased MindX to accelerate the development of highly superior brain-computer interface technologies. By merging its hardware DNA with MindX's software DNA, Blackrock hoped to increase neural data analysis while also providing flexibility and adaptation for a wide range of BCI applications.

Neurorehabilitation Devices Market, By Category

• Product:
• Neurorobotic Systems
• Brain Computer Interface
• Wearable Devices
• Brain Stimulators
• Application:
• Stroke
• Parkinson's Disease
• Brain & Spinal Cord Injury
• Cerebral Palsy
• Multiple Sclerosis
• End-User:
• Rehabilitation Centers
• Hospitals & Clinics
• Home Care
• Region:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Neurorehabilitation Devices Market, By Product

• Neurorobotic Systems
• Brain Computer Interface
• Wearable Devices
• Brain Stimulators

5. Neurorehabilitation Devices Market, By Application

• Stroke
• Parkinson's Disease
• Brain & Spinal Cord Injury
• Cerebral Palsy
• Multiple Sclerosis
• Other Applications

6. Neurorehabilitation Devices Market, By End-User

• Rehabilitation Centers
• Hospitals & Clinics
• Home Care

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Bionik Labs
• Ectron Ltd.
• REHABTRONICS INC.
• DIH International Limited (Hocoma AG)
• Abbott Laboratories (St. Jude Medical Inc.)
• MagVenture A/S
• Helius Medical Technologies
• Ekso Bionics
• Rehab-Robotics Company Limited
• Neurodan
• Rex Bionics
• Ottobock SE & Co. KGaA
• NeuroMetrix, Inc.

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References